| Product Code: ETC12541882 | Publication Date: Apr 2025 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import shipments of liposomal doxorubicin to Zambia in 2024 saw significant growth, with top exporting countries being India, South Africa, China, USA, and Denmark. The market concentration, as measured by the HHI index, remained high in 2024. The compound annual growth rate (CAGR) from 2020 to 2024 was steady at 0.24, while the growth rate from 2023 to 2024 surged by an impressive 21.93%. This indicates a growing demand for liposomal doxorubicin in Zambia, with key players continuing to dominate the market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Zambia Liposomal Doxorubicin Market Overview |
3.1 Zambia Country Macro Economic Indicators |
3.2 Zambia Liposomal Doxorubicin Market Revenues & Volume, 2021 & 2031F |
3.3 Zambia Liposomal Doxorubicin Market - Industry Life Cycle |
3.4 Zambia Liposomal Doxorubicin Market - Porter's Five Forces |
3.5 Zambia Liposomal Doxorubicin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Zambia Liposomal Doxorubicin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Zambia Liposomal Doxorubicin Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Zambia Liposomal Doxorubicin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Zambia Liposomal Doxorubicin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Zambia |
4.2.2 Growing awareness about the benefits of liposomal doxorubicin in cancer treatment |
4.2.3 Favorable government initiatives to improve healthcare infrastructure and access to advanced treatments |
4.3 Market Restraints |
4.3.1 High cost associated with liposomal doxorubicin therapy |
4.3.2 Limited availability of specialized healthcare facilities for administering liposomal doxorubicin |
4.3.3 Stringent regulatory requirements for drug approval and importation |
5 Zambia Liposomal Doxorubicin Market Trends |
6 Zambia Liposomal Doxorubicin Market, By Types |
6.1 Zambia Liposomal Doxorubicin Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Zambia Liposomal Doxorubicin Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Zambia Liposomal Doxorubicin Market Revenues & Volume, By Doxil, 2021 - 2031F |
6.1.4 Zambia Liposomal Doxorubicin Market Revenues & Volume, By Lipodox, 2021 - 2031F |
6.1.5 Zambia Liposomal Doxorubicin Market Revenues & Volume, By Myocet, 2021 - 2031F |
6.1.6 Zambia Liposomal Doxorubicin Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Zambia Liposomal Doxorubicin Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Zambia Liposomal Doxorubicin Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.3 Zambia Liposomal Doxorubicin Market Revenues & Volume, By Ovarian Cancer, 2021 - 2031F |
6.2.4 Zambia Liposomal Doxorubicin Market Revenues & Volume, By Multiple Myeloma, 2021 - 2031F |
6.2.5 Zambia Liposomal Doxorubicin Market Revenues & Volume, By Kaposi's Sarcoma, 2021 - 2031F |
6.3 Zambia Liposomal Doxorubicin Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Zambia Liposomal Doxorubicin Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Zambia Liposomal Doxorubicin Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.3.4 Zambia Liposomal Doxorubicin Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Zambia Liposomal Doxorubicin Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4 Zambia Liposomal Doxorubicin Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Zambia Liposomal Doxorubicin Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.3 Zambia Liposomal Doxorubicin Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.4 Zambia Liposomal Doxorubicin Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Zambia Liposomal Doxorubicin Market Import-Export Trade Statistics |
7.1 Zambia Liposomal Doxorubicin Market Export to Major Countries |
7.2 Zambia Liposomal Doxorubicin Market Imports from Major Countries |
8 Zambia Liposomal Doxorubicin Market Key Performance Indicators |
8.1 Patient survival rates post liposomal doxorubicin treatment |
8.2 Number of healthcare facilities offering liposomal doxorubicin therapy |
8.3 Adoption rate of liposomal doxorubicin as a preferred treatment option among healthcare providers |
9 Zambia Liposomal Doxorubicin Market - Opportunity Assessment |
9.1 Zambia Liposomal Doxorubicin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Zambia Liposomal Doxorubicin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Zambia Liposomal Doxorubicin Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Zambia Liposomal Doxorubicin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Zambia Liposomal Doxorubicin Market - Competitive Landscape |
10.1 Zambia Liposomal Doxorubicin Market Revenue Share, By Companies, 2024 |
10.2 Zambia Liposomal Doxorubicin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |